| Company Name: |
Biolab Reagents |
| Tel: |
027-65279366 18108604356 |
| Email: |
products@biolabreagent.com |
|
| | Loncastuximab Basic information |
| Product Name: | Loncastuximab | | Synonyms: | Loncastuximab;Research Grade Loncastuximab (DHD10806);Research Grade Loncastuximab;Loncastuximab (anti-CD19) | | CAS: | 1875032-68-0 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Loncastuximab Structure]() |
| | Loncastuximab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Loncastuximab Usage And Synthesis |
| Uses | Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab has antitumor activity and can be used in the research of Non-Hodgkin Lymphoma (NHL) and Diffuse Large B-cell Lymphoma (DLBCL)[1][2]. | | References | [1] Zinzani PL, et al. Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma. J Cancer Res Clin Oncol. 2022 Jan;148(1):177-190. DOI:10.1007/s00432-021-03833-x
[2] Hess B, et al. Efficacy and Safety Exposure-Response Analysis of Loncastuximab Tesirine in Patients with B cell non-Hodgkin Lymphoma. AAPS J. 2021 Dec 10;24(1):11. DOI:10.1208/s12248-021-00660-3 |
| | Loncastuximab Preparation Products And Raw materials |
|